Commencing phase I trials in Israel can be started with short notice, as no licenses are needed.
Phase II and III trials in Israel and globally require more planning and a longer timeline. Trial sponsors need to:
- Identify an appropriate clinical trial services provider
- Work with GMP regulations
- Understand regulatory and distribution timelines
Trial sponsors adding Israel as a phase II selection need to be aware of Israel’s requirements such as:
- The considerations of shipping from your clinical trial services provider into Israel
- Requirements for recertification
- Israeli QP requirements
- Returns and reconciliations
On October 28, 1pm BST/3pm IDT/9am EST, join PCI and our guests as we discuss the significant jump from phase I to phase II trials in Israel and the clinical supply chain considerations of choosing Israel as a phase II trial location.
- Moderator: Dan Millard, Business Development Manager, PCI Clinical Trial Services
- Gavin Morgan, Sr. Manager, Global Logistics, PCI Clinical Trial Services
- Paula Strauss-Levy, PCI Clinical Trial Services
- Amir Malka, IMP – Clinical Supply Services
To register for this event, please click here: